NBP 608

Drug Profile

NBP 608

Alternative Names: NBP608

Latest Information Update: 25 Apr 2017

Price : $50

At a glance

  • Originator SK Chemicals
  • Class Attenuated vaccines; Varicella vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III Herpes zoster; Varicella zoster virus infections

Most Recent Events

  • 09 Sep 2015 Phase-III clinical trials in Herpes zoster (In the elderly, Prevention, In volunteers, In adults) in South Korea (SC) (NCT03120364)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top